Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 607

1.

MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.

Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J.

Cell Signal. 2013 Dec;25(12):2693-701. doi: 10.1016/j.cellsig.2013.08.032. Epub 2013 Sep 7.

PMID:
24018051
2.

TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.

Lu F, Hou YQ, Song Y, Yuan ZJ.

Anat Rec (Hoboken). 2013 Jan;296(1):56-63. doi: 10.1002/ar.22611. Epub 2012 Nov 4.

3.

MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.

Shi L, Wu L, Chen Z, Yang J, Chen X, Yu F, Zheng F, Lin X.

Cell Physiol Biochem. 2015;35(6):2333-48. doi: 10.1159/000374036. Epub 2015 Apr 15.

4.

miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.

Yang X, Yin J, Yu J, Xiang Q, Liu Y, Tang S, Liao D, Zhu B, Zu X, Tang H, Lei X.

Oncol Rep. 2012 Jan;27(1):250-7. doi: 10.3892/or.2011.1472. Epub 2011 Sep 22.

PMID:
21947305
5.

MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.

Yang T, Zheng ZM, Li XN, Li ZF, Wang Y, Geng YF, Bai L, Zhang XB.

Exp Biol Med (Maywood). 2013 Sep;238(9):1024-32. doi: 10.1177/1535370213497321. Epub 2013 Aug 7.

PMID:
23925649
6.

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.

Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, Wang Z.

Gynecol Oncol. 2010 Oct;119(1):125-30. doi: 10.1016/j.ygyno.2010.06.004. Epub 2010 Jul 10.

PMID:
20624637
7.

MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.

Li S, Li J, Fei BY, Shao D, Pan Y, Mo ZH, Sun BZ, Zhang D, Zheng X, Zhang M, Zhang XW, Chen L.

Chin Med J (Engl). 2015 Apr 5;128(7):941-7. doi: 10.4103/0366-6999.154302.

8.

Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.

Gu W, Fang FF, Li B, Cheng BB, Ling CQ.

Asian Pac J Cancer Prev. 2012;13(9):4807-14.

9.

Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.

Sheng L, Xiong M, Li C, Meng X.

Pathol Oncol Res. 2014 Jul;20(3):541-8. doi: 10.1007/s12253-013-9726-x. Epub 2013 Dec 11.

PMID:
24327315
10.

Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.

Huang C, Xu D, Xia Q, Wang P, Rong C, Su Y.

J Pharm Pharmacol. 2012 Dec;64(12):1741-50. doi: 10.1111/j.2042-7158.2012.01549.x. Epub 2012 Jun 8.

PMID:
23146037
11.

Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.

Gu W, Liu L, Fang FF, Huang F, Cheng BB, Li B.

Oncol Rep. 2014 Jan;31(1):216-22. doi: 10.3892/or.2013.2817. Epub 2013 Oct 24.

PMID:
24173654
12.

The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.

Yuan P, Cao W, Zang Q, Li G, Guo X, Fan J.

Biochem Biophys Res Commun. 2016 Sep 23;478(3):1067-73. doi: 10.1016/j.bbrc.2016.08.065. Epub 2016 Aug 11.

PMID:
27524242
13.

Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.

Zhang H, Li M, Han Y, Hong L, Gong T, Sun L, Zheng X.

Dig Dis Sci. 2010 Sep;55(9):2545-51. doi: 10.1007/s10620-009-1051-6. Epub 2009 Dec 4.

PMID:
19960259
14.

The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.

Zhou S, Ye W, Duan X, Zhang M, Wang J.

Dig Dis Sci. 2013 Jun;58(6):1615-26. doi: 10.1007/s10620-012-2537-1. Epub 2013 Jan 12.

PMID:
23314856
15.

Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.

Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A, Kew MC, Trepo C, Wands JR.

Gastroenterology. 2004 Oct;127(4):1110-22.

PMID:
15480989
16.

MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.

Yang X, Yu J, Yin J, Xiang Q, Tang H, Lei X.

Pharmazie. 2012 Jul;67(7):645-51.

PMID:
22888524
17.

Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu.

Zhang Y, Liu G, Lin C, Liao G, Tang B.

Life Sci. 2013 May 20;92(17-19):896-902. doi: 10.1016/j.lfs.2013.03.010. Epub 2013 Apr 3.

PMID:
23562851
18.
19.

Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.

Hu C, Shen SQ, Cui ZH, Chen ZB, Li W.

World J Gastroenterol. 2015 May 21;21(19):5884-92. doi: 10.3748/wjg.v21.i19.5884.

20.

Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.

Fang P, Zhang X, Gao Y, Ding CR, Cui F, Jiao SC.

Anat Rec (Hoboken). 2012 Oct;295(10):1639-46. doi: 10.1002/ar.22551. Epub 2012 Aug 16.

Supplemental Content

Support Center